About this item:

95 Views | 45 Downloads

Author Notes:

Correspondence: Nicholas T. Seyfried, nseyfri@emory.edu

Author contributions: QG and MZ carried out the experiments. QG, MZ, SK, and ED performed the data analyses. ED did the computational analyses. QG drafted the original manuscript and figures.

QG, SK, ED, and NS wrote and edited the manuscript. NS supervised the project. QG, ED, MZ, SK, MG, JL, AL, JS, and NS reviewed and edited the manuscript. AL, JS, and NS carried out the funding acquisition. MG collected the resources. All authors contributed to the article and approved the submitted version.

Acknowledgements: We are grateful to the patients and families that donate tissue samples to the Emory University brain bank and for their contributions to this study.

Disclosures: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Subjects:

Research Funding:

Support for this research was provided by funding from the National Institute on Aging (R01AG053960, R01AG061800, RF1AG057471, RF1AG057470, R01AG057339, and RF1AG062181), the Accelerating Medicine Partnership for AD (U01AG046161 and U01AG061357), and the Emory Alzheimer’s Disease Research Center (P30AG066511).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • amyloid beta-protein
  • tau
  • RNA-binding proteins
  • Parkinson&#8217
  • s disease
  • Alzheimer&#8217
  • parallel reaction monitoring
  • mass spectrometry
  • human brains
  • Frontotemporal lobar degeneration
  • Quantitative analysis
  • Alpha synuclein
  • Lewy bodies
  • TAU
  • Beta
  • Neurodegeneration
  • Aggregation
  • Diagnosis
  • Proteome

Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease

Journal Title:

Frontiers in Molecular Neuroscience

Volume:

Volume 14

Publisher:

, Pages 623659-623659

Type of Work:

Article | Final Publisher PDF

Abstract:

Core spliceosome and related RNA-binding proteins aggregate in Alzheimer’s disease (AD) brain even in early asymptomatic stages (AsymAD) of disease. To assess the specificity of RNA-binding protein aggregation in AD, we developed a targeted mass spectrometry approach to quantify broad classes of RNA-binding proteins with other pathological proteins including tau and amyloid beta (Aβ) in detergent insoluble fractions from control, AsymAD, AD and Parkinson’s disease (PD) brain. Relative levels of specific insoluble RNA-binding proteins across different disease groups correlated with accumulation of Aβ and tau aggregates. RNA-binding proteins, including splicing factors with homology to the basic-acidic dipeptide repeats of U1-70K, preferentially aggregated in AsymAD and AD. In contrast, PD brain aggregates were relatively depleted of many RNA-binding proteins compared to AsymAD and AD groups. Correlation network analyses resolved 29 distinct modules of co-aggregating proteins including modules linked to spliceosome assembly, nuclear speckles and RNA splicing. Modules related to spliceosome assembly and nuclear speckles showed stage-specific enrichment of insoluble RBPs from AsymAD and AD brains, whereas the RNA splicing module was reduced specifically in PD. Collectively, this work identifies classes of RNA-binding proteins that distinctly co-aggregate in detergent-insoluble fractions across the specific neurodegenerative diseases we examined.

Copyright information:

© 2021 Guo, Dammer, Zhou, Kundinger, Gearing, Lah, Levey, Shulman and Seyfried.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote